When the left brain

collaborates with the right

brain, science emerges with

art to enhance communication

and understanding of research

results—illustratingconcepts,

depicting phenomena and

drawing conclusions.

The National Science Foundation (NSF)

and the journal Science, published by the

American Association for the Advancement

of Science, invite you to participate in the

seventh annual International Science

& Engineering Visualization Challenge.

The competition recognizes scientists,

engineers, visualization specialists and

artists for producing or commissioning

innovative work in visual communication.

Winners in each category will be published

in the February 19, 2010 issue of Science and

Science Online, andwill be displayed

on the NSFWeb site.

Award Catego r i e s

• Pho tog raphs /P i c tu re s• I l l u s t r a t i on s /D raw ings• I n fo rmat i ona l / E xp l anato r y

G raph i c s• I n te ra c t i ve Med i a• Non- In te ra c t i ve Med i a

I N T E R N A T I O N A L S C I E N C E & E N G I N E E R I N G

V I S U A L I Z A T I O N C H A L L E N G E

COMPETITION DEADLINE

APPROACHING

’

ENTRY DEADLINE: SEPTEMBER 15, 2009

C E I:

..//

Eighth Annual AACRInternational Conference onFrontiers in Cancer Prevention ResearchDecember 6-9, 2009 • Houston, TXChairperson: Ernest T. HawkAbstract Submission Deadline:September 28, 2009

AACR-IASLC Joint ConferenceMolecular Origins of Lung Cancer:Prospects for Personalized Prevention and TherapyJanuary 11-14, 2010 • Coronado, CAChairpersons: David P. Carbone and Roy S. Herbst

AACR 101st Annual Meeting 2010April 17-21, 2010 • Washington, DCProgram Chairperson: Frank McCormick

Third AACR Conference on The Science ofCancer Health Disparitiesin Racial/Ethnic Minorities and theMedically UnderservedSeptember 30-October 3, 2010 • Miami, FLChairpersons to be announced

Prevention-related articles from AACR journals:

• Cancer Prevention Research

• Cancer Epidemiology, Biomarkers & Prevention

• Cancer Research

• Clinical Cancer Research

• Molecular Cancer Therapeutics

• Molecular Cancer Research

Additional conference content:

• Session webcasts

• Education Book articles

Abstracts from AACR conferences:

• Frontiers in Cancer Prevention Research

• AACR Annual Meeting

• Science of Cancer Health Disparities

http://preventionportal.aacrjournals.org

For more information, contact marketing@aacr.org

Upcoming conferencesat the forefront of cancer prevention research:

Comprehensive Coverage of Cancer Prevention ScienceThrough the AACR Cancer Prevention Journals Portal

www.aacr.org/meetingcalendar

© 2009 General Electric Company – All rights reserved.First published June 2009GE Healthcare Bio-Sciences AB, Björkgatan 30, 751 84 Uppsala, Sweden

GE07-09

GE Healthcare

360° Service

I ÄKTA I Amersham I Biacore I IN Cell I Whatman I GE Service I

“These days, productivity is everything in our business. Knowing that our scientists

were losing valuable time due to service-related issues wasn’t helping. To solve

this problem and improve overall organizational efficiency, we looked at ways we

could consolidate by purchasing from fewer suppliers. GE Healthcare was the only

company that was happy to manage everything, regardless of the OEM; unbeatable

flexibility that allows our teams to focus on what they are best at. Of course,

GE Healthcare’s track record in healthcare is world-class and it’s a real benefit

having a company that is happy to manage equipment of all types.”

Richard Dickinson, Director of Operations, ERBI Ltd.

Pharmaceutical and biotech companies around the world rely on GE Service

to deliver total coverage. From instrument service agreements — including

systems from other manufacturers — to asset lifecycle management

and facility validation. Now that’s service in 360°. At GE Healthcare Life

Sciences, our focus is on helping scientists achieve even more, faster. It’s

a commitment we have in our genes. And all this is backed by the service,

support, and investment for the future that being part of GE can bring.

Find out more. Why not talk with us today.

Visit www.gelifesciences.com/360service

Gene expression and function analysis

sample and assay technologies by QIAGEN

Enjoy first-time success

Rely on QIAGEN’s manual and automated workflow solutions for:

■ Sample collection and disruption

■ RNA stabilization and purification

■ Real-time PCR and RT-PCR and gene expression assays

■ RNAi and gene silencing

■ miRNA purification and assays

■ Methylation analysis in epigenetics research

■ Protein sample preparation and assays

Making improvements in life possible — www.qiagen.com

Sample & Assay Technologies

GEFPortf0

309S1W

W

© Copyright 2009 Thomson Reuters. EndNote is a registered trademark of Thomson Reuters.

All trademarks are the property of their respective companies.

FROMSTART TO FINISH, ENDNOTE X3

KEEPS YOURRESEARCHONTHE FAST TRACK.

With its world-class speed and track record, EndNote X3 puts your

publishing in the lead and keeps you there. Out of the blocks with

new features like faster start up times and seasoned favorites like

our Cite While YouWrite™ technology, EndNote X3 is moving fast

to deliver the world’s most complete bibliographic solution.

It doesn’t stop there. EndNote X3 is alsometers ahead with a personal

EndNote Web account that not only transfers groups swiftly between

desktop andWeb but also organizes your own publication list for the

ResearcherID author community. You’ll find new speed in Cite While

YouWrite for Apple® Pages ’09, Microsoft®Word, and nowOpenOffice.org

Writer 3 for Windows. EndNote X3 even sports new options for chemistry

styles, multiple bibliographies within a Word document, and more.

Keep the lead, right to the finish line. Put EndNote X3 on your

reference team today!

800-722-1227 • 760-438-5526 • rs.info@thomson.comDownload your free demo or buy online today

www.endnote.com

Restriction Enzymes from New England BiolabsWith 35 years of experience in enzyme technology, New England Biolabs leads the industry in the study and improvement of

restriction enzymes. NEB is pleased to introduce a line of High Fidelity (HF) enzymes that have been engineered for reduced star activity.

HF enzymes bring a new level of flexibility when choosing reaction conditions, including volume, incubation time and buffer compatibility.

Make NEB your first choice and experience the exceptional performance of this next generation in restriction enzyme technology.

www.neb.com

EXCEPTIONAL PERFORMANCE

CLONING & MAPPINGDNA AMPLIFICATION

& PCRRNA ANALYSIS

PROTEIN EXPRESSION &

ANALYSIS

GENE EXPRESSION

& CELLULAR ANALYSIS

Recombinant PvuII, normally supplied in NEBuffer 2, exhibits star activity when

used in extended incubations or in alternate buffers. Star activity is significantly

reduced with PvuII-HF, even under extended incubation.

Reduced star activity with HF Enzymes from NEB

1 hr o/n 1 hr o/n 1 hr o/n M

PvuII

2

PvuII

4

PvuII-HF

4

Advantages:Selection –• More specificities than any other supplier

Convenience –• Optimal activity for over 160 enzymes

in a single buffer 4

Quality –• State-of-the-art production and stringent QCs

Innovation –• HF enzymes engineered for reduced star activity

Performance –• Guaranteed

Call forPapers

Science Signaling, from the publisher ofScience, AAAS, features top-notch, peer-reviewed, original researchweekly. Submityourmanuscripts in the following areas ofcellular regulation:

Submit your research at:www.sciencesignaling.org/about/help/research.dtl

Subscribing toScience Signaling ensuresthat you and your lab have the latest cellsignaling resources. Formore informationvisitwww.ScienceSignaling.org

• Biochemistry

• Bioinformatics

• Cell Biology

• Development

• Immunology

• Microbiology

• Molecular Biology

• Neuroscience

• Pharmacology

• Physiology andMedicine

• Systems Biology

Science Signaling is indexedin CrossRef andMEDLINE.

Chief Scientific Editor

Michael B. Yaffe, M.D., Ph.D.Associate Professor, Department of BiologyMassachusetts Institute of Technology

Editor

Nancy R. Gough, Ph.D.AAAS

Science Signaling

768

LIFE SCIENCE TECHNOLOGIES AAAS/Science Business Office

7 AUGUST 2009 VOL 325 SCIENCE www.sciencemag.org/products

New Products Focus: Liquid HandlingNew Products Focus: RNAi

Blood miRNA KitThe PAXgene Blood miRNA Kit lets researchers minimize

preanalytical variables for RNA and microRNA (miRNA). PAXgene

Blood RNA Tubes used in combination with the new miRNA kit

comprise the first system for collecting and stabilizing whole human

blood and copurifying total RNA enriched for miRNA. Systems such

as the PAXgene Blood RNA System inhibit RNA degradation and

gene induction in vitro, resulting in preservation of the gene

expression profile that is essential for accurate analysis, but

researchers cannot easily extract and purify the miRNA from these

samples. The PaxGene Blood miRNA Kit provides this ability. Both

manual and automated protocols are available.

Qiagen

For information 800-362-7737

www.qiagen.com

Reference Control ToolThe microRNA-specific miRXplore Universal Reference is a synthetic

microRNA (miRNA) pool that comprises more than 950 miRNA

oligonucleotides from human, mouse, rat, and virus. It allows direct

comparison of large numbers of samples, independent of the time of

the experiment, and allows the user to save control sample material.

The Universal Reference also serves as a hybridization control or as a

quality control to monitor miRNAmicroarray hybridization efficiency.

It can also be used as a positive control for real-time polymerase

chain reaction, cloning, and sequencing experiments.

Miltenyi Biotec

For information +49-2204-8306-6591

www.miltenyibiotec.com

Target Expression VectorThe pmirGLO Dual-Luciferase miRNA Target Expression Vector

provides researchers in microRNA (miRNA) study both the ability to

measure a wide dynamic range of miRNA activity in a vast number

of cell types and the option to create a stable cell line from one

In Vivo siRNA DeliveryMaxSuppressor RNA-LANCEr II is a nonviral transfection agent optimized

for the efficient in vivo introduction of small interfering RNA, microRNA, and

other RNA interference (RNAi) agents. The new agent is comprised of a neutral

hydrophobic emulsion that encapsulates and delivers RNAi agents directly

into tissues. Users simply mix the agent with their RNAi agent, extrude or

sonicate the mixture, and inject into an animal. It offers consistent, reliable

silencing using minimal amounts of RNAi agents.

Bioo ScientificFor information 512-707-8993www.biooscientific.com

genetic construct for further research. The pmirGLO vector makes

use of optimized firefly luciferase gene as the readout for activity,

while also offering a Renilla luciferase/neomycin resistance gene for

data normalization. The pmirGLO vector allows a luciferase reporter

gene assay to measure the function of endogenous or exogenous

miRNA and enables functional studies of sequence variations in 3'-

untranslated gene regions.

Promega

For information 608-274-4330

www.promega.com

Transcriptome ToolsThe ExactStart tools for transcriptome discovery and analysis

enable the user to selectively tag the exact 5′ end of any class of

RNA molecules in a total RNA preparation. The tagged RNA is then

converted to complementary DNA (cDNA) with unique tagging

sequencing on both ends that are customizable based on the

intended application, such as next generation sequencing. Kits are

available for small-RNA discovery and analysis, full-length cDNA

cloning, and rapid amplification of cDNA ends.

Epicentre Biotechnologies

For more information 800-284-8474

www.EpiBio.com/exactstart

Inert Pipette TipsHigh-quality BioClean pipette tips are completely inert and do not

influence experimental outcome in any way. They have been tested

by independent analysts for the absence of bioactive components

and boast a proven lack of external contaminants, including

DNA, deoxyribonuclease, ribonuclease, adenosine triphosphate,

pyrogens, and polymerase chain reaction inhibitors in the production

and packaging process.

Rainin Instrument

For information 510-564-1600

www.rainin.com

Newly offered instrumentation, apparatus, and laboratory materials of interest to researchers in all disciplines in academic, industrial, and governmental organizationsare featured in this space. Emphasis is given to purpose, chief characteristics, and availabilty of products and materials. Endorsement by Science or AAAS of any prod-ucts or materials mentioned is not implied. Additional information may be obtained from the manufacturer or supplier.

Electronically submit your new product description or product literature information! Go to www.sciencemag.org/products/newproducts.dtl for more information.

Put yourselfin the

picture.

CALL FOR ENTRIESAAAS Student Poster Competition

American Association for the Advancement of ScienceAnnual Meeting

18-22 February 2010 San Diego

“Bridging Science and Society”Submission Deadline: Friday, 23 October 2009

Don’t miss out on this opportunity to put your research in the spotlight and discuss your work with•leading scientists and engineers from across the country and around the world.

All submissions will be peer reviewed. Accepted posters will be listed in the 2010 Annual Meeting•Poster Book.

Winners will be published in• Science and at www.aaas.org/meetings.

The competition is open to college undergraduate and graduate students only.•

To learn more, including how you can volunteer and attend the Annual Meeting for free, visit

www.aaas.org/meetings

Put yourself in thepicture by entering the2010 AAAS Student

Poster Competition.

Winners receive acash prize, framedaward certi�cate,and a one-year AAASmembership—includinga subscription toScience!

R&D Systems Tools for Cell Biology Research™

USA & Canada R&D Systems, Inc. Tel: (800) 343-7475 info@RnDSystems.com

Europe R&D Systems Europe, Ltd. Tel: +44 (0)1235 529449 info@RnDSystems.co.uk

China R&D Systems China Co., Ltd. Tel: (800) 988-1270 info@RnDSystemsChina.com.cn

Selection expanding weekly—visitwww.RnDSystems.com/go/request to sign up for weekly new product updates.

R&D Systems has spent almost 25 years building its reputationas a source for high quality proteins.

Every stage of protein development takes place in R&D Systems’ laboratories, from cloning of the gene, to protein puri�cation and testing

for bioactivity. Because we control all aspects of protein manufacturing, R&D Systems can better control the quality of our products and

the technical assistance we o�er. Please visit our website atwww.RnDSystems.com/go/Proteins for more information.

R&D Systems Bioactive ProteinsHigh quality proteins aren’t a luxury, they are a necessity.

✓ Missed opportunities ✓ Non-speci�c results

✓ Experiments that can’t be repeated ✓ Weeks or months of wasted time

WHAT’S THE RISK?

R&D Systems recombinant mouseWnt-3a (Catalog # 1324-WN) andWnt-5a (Catalog # 645-

WN) promote stress �ber formation in NIH-3T3 cells, while only Wnt-3a promotes nuclear

β-Catenin accumulation. Please visit our website for information about our new high purity

humanWnt-3a (Catalog # 5036-WNP). Images Courtesy of Dr. Raymond Habas, Robert Wood

Johnson School of Medicine.

Stress Fibers

Untreated

Wnt-3a

Wnt-5a

β-Catenin Merge

FrizzledLRP5/6

Wnt

Dishevelled

APC

CK1a

β-Catenin

β-Catenin

Axin GSK-3βP

β-Catenin

TCF/LEFTargetGenes

DAAM-1

Rho

ROCK

Actin Stress Fibers

Cancer Development Endocrinology Glycobiology Immunology Neuroscience Proteases Signal Transduction Stem Cells

For research use only. Not for use in diagnostic procedures.